FR2110251A1 - - Google Patents

Info

Publication number
FR2110251A1
FR2110251A1 FR7135943A FR7135943A FR2110251A1 FR 2110251 A1 FR2110251 A1 FR 2110251A1 FR 7135943 A FR7135943 A FR 7135943A FR 7135943 A FR7135943 A FR 7135943A FR 2110251 A1 FR2110251 A1 FR 2110251A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7135943A
Other languages
French (fr)
Other versions
FR2110251B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck et Cie
Merck and Co Inc
Original Assignee
Merck et Cie
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck et Cie, Merck and Co Inc filed Critical Merck et Cie
Publication of FR2110251A1 publication Critical patent/FR2110251A1/fr
Application granted granted Critical
Publication of FR2110251B1 publication Critical patent/FR2110251B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FR7135943A 1970-10-06 1971-10-06 Expired FR2110251B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7863670A 1970-10-06 1970-10-06

Publications (2)

Publication Number Publication Date
FR2110251A1 true FR2110251A1 (enExample) 1972-06-02
FR2110251B1 FR2110251B1 (enExample) 1975-06-06

Family

ID=22145320

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7135943A Expired FR2110251B1 (enExample) 1970-10-06 1971-10-06

Country Status (6)

Country Link
US (1) US3670079A (enExample)
AU (1) AU454533B2 (enExample)
CA (1) CA968710A (enExample)
DE (1) DE2149744A1 (enExample)
FR (1) FR2110251B1 (enExample)
GB (1) GB1350114A (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013762A (en) * 1976-05-10 1977-03-22 Richardson-Merrell Inc. Growth promotion
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
CZ20023993A3 (cs) * 2000-06-26 2004-02-18 Pfizer Products Inc. Pyrolo [2,3-d]pyrimidinové sloučeniny jako imunosupresivní činidla
CN101100472A (zh) * 2001-04-30 2008-01-09 美国拜尔公司 4-氨基-5,6-取代的噻吩并[2,3-d]嘧啶化合物及其应用
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
AU2006239221C1 (en) 2005-04-28 2012-08-16 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
PL2384326T3 (pl) 2008-08-20 2014-09-30 Zoetis Services Llc Związki pirolo[2,3-d]pirymidyonowe
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
NL2022471B1 (en) 2019-01-29 2020-08-18 Vationpharma B V Solid state forms of oclacitinib

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254074A (en) * 1962-04-25 1966-05-31 Merck & Co Inc Spiroxenones

Also Published As

Publication number Publication date
GB1350114A (en) 1974-04-18
AU3384971A (en) 1973-03-29
CA968710A (en) 1975-06-03
FR2110251B1 (enExample) 1975-06-06
DE2149744A1 (de) 1972-04-13
US3670079A (en) 1972-06-13
AU454533B2 (en) 1974-10-31

Similar Documents

Publication Publication Date Title
AR204384A1 (enExample)
ATA96471A (enExample)
AU1146470A (enExample)
AU1473870A (enExample)
AU2044470A (enExample)
AU1326870A (enExample)
AU2130570A (enExample)
AU2085370A (enExample)
AU1833270A (enExample)
AU1716970A (enExample)
AU1336970A (enExample)
AU1517670A (enExample)
AU2017870A (enExample)
AU1603270A (enExample)
AU1879170A (enExample)
AU1328670A (enExample)
AU1343870A (enExample)
AU1277070A (enExample)
AU2144270A (enExample)
AU2131570A (enExample)
AU2130770A (enExample)
AU1247570A (enExample)
AU1581370A (enExample)
AU1591370A (enExample)
AU1235770A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse